Bardelli Lab

Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer dlvr.it/TM0DWX

Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer models dlvr.it/TM0Npb

ecDNA fuels cancer progression: large, mobile circles of DNA in tumors drive high oncogene copies & rapid genetic changes. Their random spread during cell division increases treatment resistance & tumor evolution. Determining therapeutic vulnerabilities & identifying target compounds to limit ecDNA evolution could open impactful new therapeutic horizons. nature.com/articles/s4158…

@CellSymposia #hallmarksofcancer One of the most amazing meeting ever!! Check out the amazing list of speakers and outstanding talks! #bigpic" target="_blank" rel="nofollow noopener">live.jimage.cn/g/2pqug9tt#big… @Albert0Bardelli

RT @christophertape: Excellent review from @mariangelaruss2 @BardelliLab discussing our current understanding of drug-tolerant persister ce…

A great overview/update of this burgeoning field! Still a lot of unanswered questions, but exciting time ahead! Happy we could contribute to this field and comprehensive overview. Thanks to @BardelliLab for taking the lead.

📢This week in @NatureRevCancer, a joint effort by many groups led by the @BardelliLab on #Cancer Persister cells. 🙌🏻It’s been a pleasure to contribute to this roadmap. ➡️rdcu.be/dSJp4

Hot off the press! We are proud to share our Roadmap on Cancer Persister Cells just published on @NatureRevCancer, a joint effort with outstanding scientists in the field to outline challenges and (exciting) future perspectives Persisters: rdcu.be/dSJp4

Excited to share the #Pezcoller23 Symposium final program, with a tremendous lineup of speakers! 💡 NEW TECHNOLOGIES FOR STUDYING AND TREATING CANCER 🗓️19-20 June 🇮🇹 Trento ⏳ Still few days to register, deadline: 31/05👉 lnkd.in/etYSdNMX @ESOncology recommended event

⁦⁩ 💞specifically for ⁦@KRASKickers energy & motivation ⁩ during #EACR2023 ⁦@AmbrogioLab⁩

Today at the #EACRCongress in Torino inspiring talk on liquid biopsy and its clinical application by dr. Marsoni. Do not miss upcoming news in the next months! @EACRnews @eacr2023

Wonderful talk by Yaara Oren kicking off the session on cancer persisters at #EACR2023. Did you know she trained as microbiologist? Thinking outside the box! @EACRnews @BardelliLab

Amazing overview of the last ten years of research in colorectal cancer pointing towards new exciting ones by Prof. Bardelli at #EACR2023. @BardelliLab @EACRnews

Great lecture of @Albert0Bardelli @BardelliLab yesterday at @EACRnews meeting explaining how targeting of MLH1 and temozolamide treatment can engage #immunotherapy response in #coloncancer

@AmbrogioLab rocking at Ras symposium today #EACR2023

Huge congratulations to EACR Board member Carlos Caldas on this award! @CaldasLab 🥳

Day 3 begins with a great talk by #ChiaraCattaneo on "Dissecting Tumor-immune Cells Interactions: Functional Models for Individual Patients". @EACRnews @IFOMresearch #EACR2023

Today at #EACR2023 Giovanni Crisafulli just presented new super interesting data on T-cell repertoire after temozolomide treatment from the #Arethusatrial patients. What’s next from this proof-of-concept trial? Stay tuned! @BardelliLab @EACRnews @eacr2023

Great talk by @fcicca Cancer-immune coevolution. Players and mechanisms of response of CRC to immunotherapy! @EACRnews #EACR2023

It is always a pleasure to watch past students of our lab to fligh high as scientists! Great #GiuliaLerda! Great talk! @EACRnews